This inventor holds 1 USPTO granted patent. Top assignee: Funbogen Ab. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: The Innovations of Anne Lunden
Introduction
Anne Lunden is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of biotechnology, particularly in the detection of mutations. Her work has implications for understanding genetic variations and their effects on health.
Latest Patents
Anne Lunden holds a patent related to the detection of mutations. The invention involves a polypeptide known as flavin-containing monooxygenase 3 (FMO3). This polypeptide comprises a sequence with at least 85% identity to the polypeptide sequence SEQ ID NO: 15. The invention focuses on a functionally altered mutant of FMO3 that leads to a buildup of trimethylamine in an animal. Additionally, it includes nucleic acid sequences encoding the polypeptide and methods for determining the presence of these sequences in nucleic acid samples.
Career Highlights
Throughout her career, Anne Lunden has demonstrated a commitment to advancing scientific knowledge. Her innovative work has garnered attention in the field of genetic research. She is recognized for her contributions to understanding the role of specific polypeptides in genetic mutations.
Collaborations
Anne has collaborated with esteemed colleagues such as Leif Andersson and Stefan Marklund. These partnerships have enhanced her research and contributed to the success of her inventions.
Conclusion
Anne Lunden's work in the detection of mutations showcases her innovative spirit and dedication to biotechnology. Her contributions are valuable to the scientific community and have the potential to impact health-related research significantly.